ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,524Medicare Part D Prescriptions Filled, Including Refills

Rank: 197 out of 3734

$844K Total Retail Price of All Prescriptions

Rank: 187 out of 3734

487 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,585 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
JANTOVEN 1,049 812 1 76
OMEPRAZOLE 537 421 2 4
LEVOTHYROXINE SODIUM 421 334 3 2
SIMVASTATIN 374 294 4 1
SERTRALINE HCL 337 299 5 18
LISINOPRIL 327 268 6 3
HYDROCODONE-ACETAMINOPHEN 309 208 S3 7 12
FUROSEMIDE 305 265 8 7
METOPROLOL TARTRATE 259 234 9 6
GABAPENTIN 257 114 10 17
MIRTAZAPINE 249 210 11 45
IPRATROPIUM-ALBUTEROL 217 165 12 98
CITALOPRAM HBR 212 154 13 16
POTASSIUM CHLORIDE 203 175 14 19
AMLODIPINE BESYLATE 199 150 15 5
DONEPEZIL HCL 182 168 16 25
METFORMIN HCL 169 114 17 8
BUMETANIDE 157 134 18 78
OXYCODONE HCL 155 23 S2 19 58
METOPROLOL SUCCINATE 153 128 20 14
ADVAIR DISKUS 148 96 21 35
LEVEMIR 131 108 22 202
RISPERIDONE 127 94 23 62
CARVEDILOL 124 89 24 30
MORPHINE SULFATE ER 119 19 S2 25 104
PRAVASTATIN SODIUM 118 95 26 15
FAMOTIDINE 118 110 26 60
DIVALPROEX SODIUM 118 63 26 99
NOVOLOG 115 83 29 112
OXYCONTIN 114 45 S2 30 121
TAMSULOSIN HCL 108 93 31 29
RANITIDINE HCL 106 53 32 32
ALENDRONATE SODIUM 103 92 33 26
QUETIAPINE FUMARATE 99 81 34 82
SPIRIVA 98 66 35 40
POLYETHYLENE GLYCOL 3350 98 85 35 53
PREDNISONE 96 56 37 42
TRAMADOL HCL 95 71 38 20
NAMENDA 93 78 39 44
CYMBALTA 93 56 39 67
PANTOPRAZOLE SODIUM 92 81 41 22
MORPHINE SULFATE 88 67 S2 42 220
ATORVASTATIN CALCIUM 82 67 43 11
LANTUS 81 58 44 54
WARFARIN SODIUM 80 76 45 10
ATENOLOL 79 73 46 13
CLOPIDOGREL 76 64 47 23
CARBIDOPA-LEVODOPA 76 70 47 92
LOSARTAN POTASSIUM 75 66 49 21
BUSPIRONE HCL 74 57 50 129
CARISOPRODOL 73 15 R 51 134
HYDROCHLOROTHIAZIDE 73 70 51 9
CYCLOBENZAPRINE HCL 72 31 R 53 87
FLUTICASONE PROPIONATE 70 30 54 46
CIPROFLOXACIN HCL 70 59 54 77
GLYBURIDE 67 43 R 56 64
ALLOPURINOL 66 62 57 33
AZITHROMYCIN 65 43 58 38
PAROXETINE HCL 64 58 59 59
LEVETIRACETAM 63 49 60 105
ARANESP 63 0 60 409
ZOLPIDEM TARTRATE 60 18 62 24
AMITRIPTYLINE HCL 57 15 R 63 94
SEROQUEL 54 48 64 161
LEVOFLOXACIN 54 48 64 116
PHENYTOIN SODIUM EXTENDED 53 38 66 149
AMLODIPINE BESYLATE-BENAZEPRIL 53 48 66 56
FINASTERIDE 53 53 66 88
BACLOFEN 53 33 66 142
FENOFIBRATE 51 30 70 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.